
COMPASS Pathways Plc American Depository Shares
CMPS
CMPS: Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.
moreShow CMPS Financials
Recent trades of CMPS by members of U.S. Congress
Politician | Type | Traded |
---|---|---|
Shri Thanedar House / D | Sale $1,001 - $15,000 | Jan. 23, 2023 |
Recently reported changes by institutional investors
Quarterly net insider trading by CMPS's directors and management
Government lobbying spending instances
New patents grants
-
Patent Title: Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use Dec. 31, 2019
Federal grants, loans, and purchases
Followers on CMPS's company Twitter account
Number of mentions of CMPS in WallStreetBets Daily Discussion
Recent insights relating to CMPS
Recent picks made for CMPS stock on CNBC
ETFs with the largest estimated holdings in CMPS
Flights by private jets registered to CMPS